Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Anthrax Vaccine Market size study by Vaccine Type (Cell-Free PA Vaccine and Live Attenuated Vaccine), Application (Animal Use and Human Use), Distribution Channel (Hospitals, Pharmacies, and Other Distribution Channels), Regional Forecasts 2021-2027

  • BIZ4660720
  • 200 Pages
  • October 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Anthrax Vaccine Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.85% over the forecast period 2021-2027. Anthrax is a deadly disease caused by the spore-forming bacteria Bacillus anthracis. The illness mostly affects cattle and wild game. Humans, on the other hand, can become infected with anthrax bacterium through direct or indirect contact with animals that have anthrax. The bacterium that causes anthrax enters the human body through a skin wound. Furthermore, inhaling bacterial spores and eating infected meat might result in infection. Anthrax symptoms include skin lesions, fever, and vomiting. A three-dose regimen of anthrax vaccinations is used to prevent anthrax. Cell-free protective agent (PA) vaccinations and live anthrax vaccines are two common kinds of anthrax vaccines. The market is driven by the key factors such as increased consumption of undercooked/raw meat and growing burden of anthrax globally. According to the Agricultural Economic Insights (AEI) research, meat consumption in the United States increased from 1970 to 2020. Although the eating patterns of chicken, beef, and pork differ drastically, it raises the risk of anthrax. Furthermore, rise in technological development globally boost the market demand in the forecast years. For instance, In August 2020, Dr. Jamie Benn Felix and the Cook Wildlife Lab team with Texas A&M University College of Veterinary Medicine & Biomedical Sciences conducted a pilot trial for the first oral anthrax vaccination for cattle. However, high cost associated with vaccine may impede market growth over the forecast period of 2021-2027.

The North American market is dominating the market of anthrax vaccine. In terms of revenue, the United States dominates the North American market. The European market is quickly developing because of an increasing patient population, particularly in the United Kingdom and Germany. Asia Pacific and Latin American markets are expected to grow considerably in the foreseeable future. Developing economies such as China and India are expected to contribute to the growth of the Asia Pacific market owing to improved health care infrastructure, economic growth, an increase in the number of insurance payers, the expansion of the private health care sector, and increased awareness in these countries.

Major market player included in this report are:

Colondo Serum Co

Emergent BioSolutions

Indian Immunologicals Limited

Proton Biopharma Ltd

Biogenesis Bago

Merck & Co. Inc.

Zoetis Inc.

Bayer AG

Altimmune (PharmAthene Inc.)

Agrovet

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Vaccine type:

Live Attenuated Vaccine

Cell Free PA Vaccine

By Application:

Animal Use

Human Use

By Distribution Channel:

Hospitals

Pharmacies

Other Distribution Channels

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027.

Target Audience of the Global Anthrax Vaccine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Anthrax Vaccine Market, by Region, 2019-2027 (USD Billion)

1.2.2. Anthrax Vaccine Market, by Vaccine type, 2019-2027 (USD Billion)

1.2.3. Anthrax Vaccine Market, by Application, 2019-2027 (USD Billion)

1.2.4. Anthrax Vaccine Market, by Distribution Channel, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Anthrax Vaccine Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Anthrax Vaccine Market Dynamics

3.1. Anthrax Vaccine Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increased consumption of undercooked/raw meat

3.1.1.2. Growing burden of anthrax globally

3.1.2. Market Restraint

3.1.2.1. High cost associated with vaccine

3.1.2.2. Lack of awareness for diagnostic test of target disease

3.1.3. Market Opportunities

3.1.3.1. Technological development

Chapter 4. Global Anthrax Vaccine Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Anthrax Vaccine Market, by Vaccine type

5.1. Market Snapshot

5.2. Global Anthrax Vaccine Market by Vaccine type , Performance - Potential Analysis

5.3. Global Anthrax Vaccine Market Estimates & Forecasts by Vaccine type 2018-2027 (USD Billion)

5.4. Anthrax Vaccine Market , Sub Segment Analysis

5.4.1. Live Attenuated Vaccine

5.4.2. Cell Free PA Vaccine

Chapter 6. Global Anthrax Vaccine Market, by Application

6.1. Market Snapshot

6.2. Global Anthrax Vaccine Market by Application, Performance - Potential Analysis

6.3. Global Anthrax Vaccine Market Estimates & Forecasts by Application 2018-2027 (USD Billion)

6.4. Anthrax Vaccine Market , Sub Segment Analysis

6.4.1. Animal Use

6.4.2. Human Use

Chapter 7. Global Anthrax Vaccine Market, by Distribution Channel

7.1. Market Snapshot

7.2. Global Anthrax Vaccine Market by Distribution Channel, Performance - Potential Analysis

7.3. Global Anthrax Vaccine Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)

7.4. Anthrax Vaccine Market , Sub Segment Analysis

7.4.1. Hospitals

7.4.2. Pharmacies

7.4.3. Other Distribution Channels

Chapter 8. Global Anthrax Vaccine Market, Regional Analysis

8.1. Anthrax Vaccine Market , Regional Market Snapshot

8.2. North America Anthrax Vaccine Market

8.2.1. U.S. Anthrax Vaccine Market

8.2.1.1. Vaccine type breakdown estimates & forecasts, 2018-2027

8.2.1.2. Application breakdown estimates & forecasts, 2018-2027

8.2.1.3. Distribution Channel breakdown estimates & forecasts, 2018-2027

8.2.2. Canada Anthrax Vaccine Market

8.3. Europe Anthrax Vaccine Market Snapshot

8.3.1. U.K. Anthrax Vaccine Market

8.3.2. Germany Anthrax Vaccine Market

8.3.3. France Anthrax Vaccine Market

8.3.4. Spain Anthrax Vaccine Market

8.3.5. Italy Anthrax Vaccine Market

8.3.6. Rest of Europe Anthrax Vaccine Market

8.4. Asia-Pacific Anthrax Vaccine Market Snapshot

8.4.1. China Anthrax Vaccine Market

8.4.2. India Anthrax Vaccine Market

8.4.3. Japan Anthrax Vaccine Market

8.4.4. Australia Anthrax Vaccine Market

8.4.5. South Korea Anthrax Vaccine Market

8.4.6. Rest of Asia Pacific Anthrax Vaccine Market

8.5. Latin America Anthrax Vaccine Market Snapshot

8.5.1. Brazil Anthrax Vaccine Market

8.5.2. Mexico Anthrax Vaccine Market

8.6. Rest of The World Anthrax Vaccine Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Colorado Serum Co

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. Emergent BioSolutions

9.2.3. Indian Immunologicals Ltd

9.2.4. Porton Biopharma Ltd

9.2.5. Biogenesis Bago

9.2.6. Merck & Co. Inc.

9.2.7. Zoetis Inc.

9.2.8. Bayer AG

9.2.9. Altimmune (PharmAthene Inc.)

9.2.10. Agrovet

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. Global Anthrax Vaccine Market, report scope

TABLE 2. Global Anthrax Vaccine Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Anthrax Vaccine Market estimates & forecasts by Vaccine type 2018-2027 (USD Billion)

TABLE 4. Global Anthrax Vaccine Market estimates & forecasts by Application 2018-2027 (USD Billion)

TABLE 5. Global Anthrax Vaccine Market estimates & forecasts by Distribution Channel 2018-2027 (USD Billion)

TABLE 6. Global Anthrax Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Anthrax Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Anthrax Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Anthrax Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Anthrax Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Anthrax Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Anthrax Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Anthrax Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Anthrax Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Anthrax Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Anthrax Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Anthrax Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Anthrax Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Anthrax Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Global Anthrax Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. Global Anthrax Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. U.S. Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. U.S. Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. U.S. Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. Canada Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 26. Canada Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. Canada Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. UK Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 29. UK Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. UK Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. Germany Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 32. Germany Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. Germany Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. France Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 35. France Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. France Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. Spain Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 38. Spain Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Spain Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. Italy Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 41. Italy Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. Italy Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. ROE Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 44. ROE Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. ROE Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. China Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 47. China Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. China Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. India Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 50. India Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. India Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. Japan Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 53. Japan Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Japan Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. Australia Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 56. Australia Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 57. Australia Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 58. South Korea Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 59. South Korea Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 60. South KoreaAnthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 61. ROPAC Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 62. ROPAC Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 63. ROPAC Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 64. Brazil Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 65. Brazil Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 66. Brazil Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 67. Mexico Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 68. Mexico Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 69. Mexico Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 70. ROLA Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 71. ROLA Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 72. ROLA Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 73. ROW Anthrax Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 74. ROW Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 75. ROW Anthrax Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 76. List of secondary sources used in the study of Global Anthrax Vaccine Market.

TABLE 77. List of primary sources used in the study of Global Anthrax Vaccine Market.

TABLE 78. Years considered for the study.

TABLE 79. Exchange rates considered.

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research